Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print September 16, 2008, 10.1097/PSY.0b013e31818434ab
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by al'Absi, M.
Right arrow Articles by Westra, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by al'Absi, M.
Right arrow Articles by Westra, R.
Related Collections
Right arrow Neuroendocrine
Right arrow Pain
Right arrow Stress and Coping
Right arrow Substance Abuse
Psychosomatic Medicine 70:928-935 (2008)
© 2008 American Psychosomatic Society


ORIGINAL ARTICLES

Blunted Opiate Modulation of Hypothalamic-Pituitary-Adrenocortical Activity in Men and Women Who Smoke

Mustafa al'Absi, PhD, Lorentz E. Wittmers, MD, PhD, Dorothy Hatsukami, PhD and Ruth Westra, DO

From the Departments of Behavioral Sciences (M.A.), Family Medicine (M.A., R.W.), Physiology/Pharmacology (M.A., L.E.W.), and Psychiatry (D.H.), University of Minnesota Medical School, Duluth, Minnesota.

Address correspondence and reprint requests to Mustafa al'Absi, Department of Behavioral Sciences, University of Minnesota Medical School, Duluth, MN 55812. E-mail: malabsi{at}umn.edu

Objective: To examine the extent to which nicotine dependence alters endogenous opioid regulation of the hypothalamic-pituitary-adrenocortical (HPA) axis functions. Endogenous opiates play an important role in regulating mood, pain, and drug reward. They also regulate the HPA functions. Previous work has demonstrated an abnormal HPA response to psychological stress among dependent smokers.

Methods: Smokers and nonsmokers (total n = 48 participants) completed two sessions during which a placebo or 50 mg of naltrexone was administered, using a double-blind design. Blood and saliva samples, cardiovascular and mood measures were obtained during a resting absorption period, after exposure to two noxious stimuli, and during an extended recovery period. Thermal pain threshold and tolerance were assessed in both sessions. Participants also rated pain during a 90-second cold pressor test.

Results: Opioid blockade increased adrenocorticotropin, plasma cortisol, and salivary cortisol levels; these increases were enhanced by exposure to the noxious stimuli. These responses were blunted in smokers relative to nonsmokers. Smokers tended to report less pain than nonsmokers, and women reported more pain during both pain procedures, although sex differences in pain were significant only among nonsmokers.

Conclusions: We conclude that nicotine dependence is associated with attenuated opioid modulation of the HPA. This dysregulation may play a role in the previously observed blunted responses to stress among dependent smokers.

Key Words: smoking • endogenous opioids • cortisol • adrenocorticotropin • stress • pain • naltrexone

Abbreviations: ACTH = adrenocorticotropin; BP = blood pressure; CO = cardiac output; CPT = cold pressor test; CRF = corticotrophin-releasing factor; HPA = hypothalamic-pituitary-adrenocortical; MPQ = McGill Pain Questionnaire.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Psychosomatic Society